The genetic history of Scandinavia from the Roman Iron Age to the present

We investigate a 2,000-year genetic transect through Scandinavia spanning the Iron Age to the present, based on 48 new and 249 published ancient genomes and genotypes from 16,638 modern individuals. We find regional variation in the timing and magnitude of gene flow from three sources: the eastern Baltic, the British-Irish Isles, and southern Europe. British-Irish ancestry was widespread in Scandinavia from the Viking period, whereas eastern Baltic ancestry is more localized to Gotland and central Sweden. In some regions, a drop in current levels of external ancestry suggests that ancient immigrants contributed proportionately less to the modern Scandinavian gene pool than indicated by the ancestry of genomes from the Viking and Medieval periods. Finally, we show that a north-south genetic cline that characterizes modern Scandinavians is mainly due to the differential levels of Uralic ancestry and that this cline existed in the Viking Age and possibly earlier.

Is Dupuytren's disease really a 'disease of the Vikings'?

It has been suggested that Dupuytren's disease has an origin in Norse countries. We harnessed data from a genome-wide association study of Dupuytren's disease and the People of the British Isles study to determine evidence for a Norse origin of Dupuytren's disease. We computed Wright's Fixation Index between Orkney (Norse ancestry), Wales (ancient British) and South East England (Anglo-Saxons); compared mean Wright's Fixation Index in cases versus controls; used permutation to determine any excess of Norse inheritance in disease associated variants; constructed a genetic risk score for Dupuytren's disease and applied this to the People of the British Isles dataset to look for systematic differences between counties with known high and low levels of Norse ancestry. Finally, chromosome painting was used to see whether Dupuytren's disease-associated single nucleotide polymorphisms are geographically structured. In all analyses, no evidence was found for an excess of Norse ancestry in Dupuytren's disease. We conclude that there is no genetic evidence for a 'Viking origin of Dupuytren's disease'.

Bacillus glennii sp. nov. and Bacillus saganii sp. nov., isolated from the vehicle assembly building at Kennedy Space Center where the Viking spacecraft were assembled

Two Gram-stain-positive, motile, endospore-forming, aerobic strains, designated V44-8^T and V47-23a^T, were isolated from environmental air sampling at the vehicle assembly building at Cape Canaveral, Florida, where the Viking spacecraft were assembled. Growth was observed at pH 7-9 (optimum, pH 9) for strain V44-8^T, and pH 5-10 (pH 9) for strain V47-23a^T. Both strains displayed growth in 0-5 % NaCl with an optimum at 1 % for strain V44-8^T; 0 % for strain V47-23a^T. Strains V44-8^T and V47-23a^T grew optimally at 32 °C, (15-32 °C) and 25 °C (20-45 °C), respectively. The cell wall of both strains contained meso-diaminopimelic acid as the diagnostic diamino acid. Both strains contained phosphatidylglycerol, phosphatidylethanolamine and diphosphatidylglycerol. The predominant cellular fatty acids were anteiso-C_15 : 0, iso-C_14 : 0 and iso-C_15 : 0. Strain V47.23a^T shared its highest 16S rRNA sequence similarity with Bacillus cavernae DSM-105484^T at 96.9%, and V44.8^T with Bacillus zeae DSM-103964^T at 96.6 %. Based on their phenotypic characteristics and phylogenetic position inferred from 16S rRNA gene sequence analyses, the isolates were identified as being a members of the genus Bacillus that forms a separate clade when compared to close relatives. Average nucleotide identity and average amino acid identity values between strains V44-8^T and DSM-103964^T were 72.1% and 67.5 %; V47-23a^T and DSM-105484^T were 62.4% and 69.1%, respectively. Based on the phenotypic, genomic and biochemical data, strains V44-8^T and V47-23a^T represent two novel species in the genus Bacillus for which the names Bacillus glennii sp. nov. [type strain, V44-8^T (=ATCC BAA-2860^T =DSM 105192^T)], and Bacillus saganii sp. nov. [V47-23a^T (=ATCC BAA-2861^T=DSM 105190^T)] are proposed.